ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.049,00
-0,46%
S&P 500
5.116,17
0,32%
Dow Jones
38.386,09
0,38%
Euro vs US Dollar
1,07231
0,07%
Bitcoin
61.484,46
-3,69%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Quanterix Corporation (QTRX)

  7. Quanterix Corporation (QTRX) News

QTRX Quanterix Corporation

15,58
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 13:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Quanterix Corporation QTRX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 15,58 13:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
15,58
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202422:00BWQuanterix To Report First Quarter 2024 Financial Results
21.3.202422:30BWQuanterix Outlines Partner Path With Labs to Expedite..
04.3.202423:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
04.3.202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202415:00BWQuanterix Granted Breakthrough Device Designation from U.S...
29.2.202422:58EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202422:00BWQuanterix Releases Operating Results for Fourth Quarter and..
27.2.202400:58BWQuanterix Reschedules Q4 and Full Year 2023 Earnings..
26.2.202415:00BWQuanterix Announces First Collaborations with Five Health..
23.2.202422:30BWQuanterix to Present at Cowen’s 44th Annual Health Care..
16.2.202422:00BWQuanterix Fourth Quarter Earnings and Full Year 2023..
15.2.202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.2.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202422:05EDGAR2Form 8-K - Current report
04.1.202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202423:21EDGAR2Form 144 - Report of proposed sale of securities
12.12.202322:00BWQuanterix to Present at 42nd Annual J.P. Morgan Healthcare..
01.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:00BWQuanterix To Participate at The Canaccord Genuity MedTech,..
13.11.202313:00GLOBESotera Health Appoints Karen Flynn to Board of Directors
06.11.202323:56BWQuanterix Releases Operating Results for Third Quarter 2023
06.11.202323:03EDGAR2Form 8-K - Current report
06.11.202322:50BWQuanterix Releases Operating Results for Third Quarter 202
01.11.202314:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:00BWQuanterix to Report Third Quarter 2023 Financial Results on..
24.10.202322:30BWQuanterix Launches High Accuracy p-Tau 217 Blood Biomarker..
24.10.202302:30BWQuanterix Announces New Agreement to Advance Blood Based..
02.10.202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.9.202323:00BWQuanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease..
06.9.202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202314:00BWQuanterix to Participate at the Morgan Stanley 21st Annual..
22.8.202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.8.202322:02EDGAR2Form 8-K - Current report
21.8.202322:30BWWilliam P. Donnelly Appointed to Quanterix’s Board of..
09.8.202314:52EDGAR2Form 8-K - Current report
09.8.202314:30BWQuanterix Appoints Vandana Sriram as Chief Financial Officer
08.8.202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202323:21EDGAR2Form 8-K - Current report
07.8.202323:13BWQuanterix Releases Operating Results for Second Quarter 2023
03.8.202314:00BWQuanterix to Present at Canaccord Genuity 43rd Annual Growth..
02.8.202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.7.202314:00BWQuanterix’s Simoa® Technology Powers Large, International..
20.7.202314:00BWQuanterix to Report Second Quarter 2023 Financial Results on..
06.7.202323:37BWQuanterix Launches LucentAD Biomarker Blood Test to Aid..
05.7.202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202322:00BWQuanterix to Participate in Fireside Chat at Goldman Sachs..

Kürzlich von Ihnen besucht

NASDAQ
QTRX
Quanterix
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten